Brought to you by:
Elective PVI for claudication linked to worse limb outcomes and higher costs
Vascular surgeons have long debated whether and when to intervene on claudication. A new study suggests the field may be intervening too often, too early and with consequences that compound over time. The findings, recently published in the Journal of…
Data support conservative approach to claudication in elderly patients
Claudication rarely takes a limb. But in patients over 80, the attempt to treat it surgically may take something just as important. New data, presented at VAM 2026 by Jeffrey Siracuse, MD, makes the case that for octogenarians with intermittent…
Pre-operative guideline adherence tied to fewer major adverse limb events
For patients with claudication, surgical revascularization is meant to restore quality of life. But a new retrospective study finds that most patients are arriving for that intervention without completing the pre-operative care that guidelines recommend and that the shortfall carries…
Tibial access in claudicants linked to guideline-discordant care and CLTI progression
Retrograde tibial access has long offered technical advantages in peripheral vascular procedures, but a new study raises concern that its use in patients with claudication may be driving treatment decisions that exceed what current guidelines recommend, creating a clinically significant…
Study strengthens case for conservative therapy in claudication over early intervention
Early peripheral vascular intervention (PVI) for claudication is associated with higher rates of progression to chronic limb-threatening ischemia (CLTI) and major adverse limb events (MALE) compared with conservative medical management, according to data presented at the 2026 annual winter meeting of the…
Claudication: Medicare-linked data outline higher rates of progression to CLTI after revascularization among Black women
Black women with claudication had the highest rate of progression to chronic limb-threatening ischemia (CLTI) after lower extremity revascularization at 180 days, new data from a Medicare-linked Vascular Quality Initiative (VQI) procedural registry show. The results were demonstrated in a…
‘The patient is there to see me and my face’: Making shared decision-making central to vascular care
Matthew Corriere, MD, believes a major shift is needed in how clinicians communicate and make decisions with their patients. During the 2025 distinguished address given at the New England Society for Vascular Surgery (NESVS) annual meeting in Providence, Rhode Island…
Study details aspects of early care improvements after publication of SVS appropriate use criteria for claudication
An observational study of intermittent claudication (IC) practice patterns before and after publication of the Society for Vascular Surgery (SVS) appropriate use criteria (AUC) for IC management points to a series of areas where care has improved, alongside aspects still…
Endovascular CFA treatment associated with increased rate of long-term CFA-specific reintervention, study finds
A recent study suggests that endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless of indication. Nicholas Wells, a medical student at Yale School of Medicine in New Haven, USA,…
Endovascular CFA treatment associated with increased rate of long-term CFA-specific reintervention, study finds
A recent study suggests that endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless of indication. Nicholas Wells, MA, a medical student at Yale School of Medicine in New Haven,…